|
|
.
See Category: Factors influencing health status and contact with health services
ICD-10 (CM) Code and Descriptor
|
Z12.9 |
Encounter for screening for malignant neoplasm, site unspecified
This code is considered unacceptable as a principal diagnosis.
|
Z129 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 15.34%
|
20.63%
|
16.19%
|
10.98%
|
8.12%
|
6.69%
|
5.56%
|
5.54%
|
3.29%
|
2.54%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z12.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
761
|
763
|
|
80053
|
COMPREHEN METABOLIC PANEL |
618
|
618
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
540
|
540
|
|
80061
|
LIPID PANEL |
487
|
487
|
|
71271
|
CT THORAX LUNG CANCER SCR C- |
392
|
392
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
377
|
378
|
|
84443
|
ASSAY THYROID STIM HORMONE |
276
|
276
|
|
G1004
|
CDSM NDSC |
264
|
277
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
263
|
263
|
|
82274
|
ASSAY TEST FOR BLOOD FECAL |
186
|
186
|
|
84153
|
ASSAY OF PSA TOTAL |
175
|
175
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
175
|
175
|
|
82306
|
VITAMIN D 25 HYDROXY |
157
|
157
|
|
G0103
|
PSA SCREENING |
137
|
137
|
|
85610
|
PROTHROMBIN TIME |
126
|
126
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
120
|
11,440
|
|
76700
|
US EXAM ABDOM COMPLETE |
119
|
119
|
|
82105
|
ALPHA-FETOPROTEIN SERUM |
118
|
119
|
|
80048
|
METABOLIC PANEL TOTAL CA |
113
|
113
|
|
85027
|
COMPLETE CBC AUTOMATED |
109
|
109
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z12.9 related to the following DRG Codes:
951
|
